PT100949A - Derivados de piridinol tri-substituidos e composicoes farmaceuticas, seu processo de preparacao e uso como medicamentos - Google Patents
Derivados de piridinol tri-substituidos e composicoes farmaceuticas, seu processo de preparacao e uso como medicamentosInfo
- Publication number
- PT100949A PT100949A PT100949A PT10094992A PT100949A PT 100949 A PT100949 A PT 100949A PT 100949 A PT100949 A PT 100949A PT 10094992 A PT10094992 A PT 10094992A PT 100949 A PT100949 A PT 100949A
- Authority
- PT
- Portugal
- Prior art keywords
- medications
- tri
- preparation
- pharmaceutical compositions
- use procedure
- Prior art date
Links
- -1 TRI-SUBSTITUTED PYRIDINOL Chemical class 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/58—Pyridine rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB919121651A GB9121651D0 (en) | 1991-10-11 | 1991-10-11 | Chemical compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT100949A true PT100949A (pt) | 1994-06-30 |
Family
ID=10702801
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT100949A PT100949A (pt) | 1991-10-11 | 1992-10-09 | Derivados de piridinol tri-substituidos e composicoes farmaceuticas, seu processo de preparacao e uso como medicamentos |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0607217A1 (pt) |
| JP (1) | JPH07500102A (pt) |
| AU (1) | AU654051B2 (pt) |
| CA (1) | CA2120756A1 (pt) |
| GB (1) | GB9121651D0 (pt) |
| MX (1) | MX9205851A (pt) |
| PT (1) | PT100949A (pt) |
| WO (1) | WO1993007137A1 (pt) |
| ZA (1) | ZA927786B (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4323916A1 (de) * | 1993-07-16 | 1995-01-19 | Basf Ag | Substituierte 2-Phenylpyridine |
| DE102004050196A1 (de) * | 2004-10-15 | 2006-04-20 | Sanofi-Aventis Deutschland Gmbh | Substituierte 2-Pyridon-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Medikament |
| CN101602687A (zh) * | 2008-06-13 | 2009-12-16 | 上海特化医药科技有限公司 | 6-硝基苯乙酮类化合物、其制备方法及用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8809481D0 (en) * | 1988-04-21 | 1988-05-25 | Smith Kline French Lab | Chemical compounds |
| GB8923131D0 (en) * | 1989-10-13 | 1989-11-29 | Smith Kline French Lab | Chemical compounds |
| PT97722A (pt) * | 1990-05-21 | 1992-02-28 | Smith Kline French Lab | Processo de preparacao de derivados de aril fenol/piridinol condesados e de composicoes farmaceuticas que os contem |
-
1991
- 1991-10-11 GB GB919121651A patent/GB9121651D0/en active Pending
-
1992
- 1992-10-09 WO PCT/GB1992/001847 patent/WO1993007137A1/en not_active Application Discontinuation
- 1992-10-09 MX MX9205851A patent/MX9205851A/es unknown
- 1992-10-09 EP EP92920748A patent/EP0607217A1/en not_active Withdrawn
- 1992-10-09 ZA ZA927786A patent/ZA927786B/xx unknown
- 1992-10-09 AU AU26933/92A patent/AU654051B2/en not_active Ceased
- 1992-10-09 PT PT100949A patent/PT100949A/pt not_active Application Discontinuation
- 1992-10-09 JP JP5506756A patent/JPH07500102A/ja active Pending
- 1992-10-09 CA CA002120756A patent/CA2120756A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ZA927786B (en) | 1994-04-11 |
| GB9121651D0 (en) | 1991-11-27 |
| AU2693392A (en) | 1993-05-03 |
| JPH07500102A (ja) | 1995-01-05 |
| MX9205851A (es) | 1993-06-01 |
| AU654051B2 (en) | 1994-10-20 |
| CA2120756A1 (en) | 1993-04-15 |
| WO1993007137A1 (en) | 1993-04-15 |
| EP0607217A1 (en) | 1994-07-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI943571A (fi) | 1-bentseenisulfonyyli-1,3-dihydro-2H-bentsimidatsol-2-onijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset | |
| IT1219811B (it) | Derivati peptidici,loro preparazione e loro impiego come medicamenti | |
| FI942913A0 (fi) | Isatiinijohdannaiset, menetelmät niiden valmistamiseksi ja niitä sisältävät farmaseuttiset koostumukset | |
| IT8947823A0 (it) | Derivati peptidici, loro preparazione e loro impiego come medicamenti | |
| IT1200092B (it) | Derivati amminopropossi, loro preparazione e loro impiego come medicamenti | |
| FI951789A (fi) | Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät farmaseuttiset koostumukset | |
| IT1203743B (it) | Peptidi e derivati peptidici,loro preparazione e loro impiego come medicamenti | |
| ITMI912237A0 (it) | Derivati di geneserina loro preparazione e composizioni farmaceutiche che li contengono | |
| IT1219542B (it) | Derivati pepticidi,loro preparazione e loro impiego come medicamenti | |
| IT1237474B (it) | Composti tripeptidici e loro uso farmaceutico come immuno-modulatori | |
| ITMI911520A0 (it) | Derivati di piperidina, loro preparazione e uso | |
| IT1297205B1 (it) | Composizioni farmaceutiche di somatostatina con assorbimento migliorato, loro preparazione e loro impiego | |
| IT1227436B (it) | Derivati di 1-azabicicloalcani, loro procedimento di preparazione e loro applicazione come farmaci | |
| KR900012897A (ko) | 구아니딘 유도체 및 이를 함유하는 약제학적 조성물 | |
| FI961977A (fi) | N-substituoidut atsabisykloalkaanijohdannaiset, niiden valmistus ja käyttö | |
| FI945439A0 (fi) | Uusia taksaanijohdannaisia, niiden valmistus ja niitä sisältävät koostumukset | |
| PT100949A (pt) | Derivados de piridinol tri-substituidos e composicoes farmaceuticas, seu processo de preparacao e uso como medicamentos | |
| DE3782378D1 (de) | Dihydropyridinderivate und deren pharmazeutische zusammensetzungen. | |
| FR2636063B1 (fr) | Composes phenylpyrroliques utiles en tant que medicaments, leur preparation et leur application | |
| IT8948610A0 (it) | Derivati ciclici e loro metaboliti, loro preparazione e composizioni farmaceutiche che li contengono | |
| IT9021305A0 (it) | Derivati aminopropanolici, procedimenti per la loro preparazione e composizioni farmaceutiche che li contengono | |
| NO921908D0 (no) | Aminosyreazetidinylsubstituerte pyridonderivater, deres fremstilling og anvendelse som medikamenter | |
| IL104347A0 (en) | Substituted benzimidazole derivatives,their preparation and pharmaceutical compositions containing them | |
| ITMI910846A1 (it) | Derivati di flavoni, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono | |
| IT8548195A0 (it) | Derivati della naftossazina, loro preparazione, loro applicazione come medicamenti e composizioni farmaceutiche che li contengono |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BB1A | Laying open of patent application |
Effective date: 19931122 |
|
| FC3A | Refusal |
Effective date: 19990503 |